Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Allergan, Medytox Enter Licensing Deal | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Allergan, Medytox Enter Licensing Deal

To develop and commercialize neurotoxin products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan, Inc. and Medytox, Inc. have entered into a license agreement under which Allergan gains exclusive worldwide rights, outside of Korea, to develop and commercialize certain neurotoxin product candidates currently in development, including a potential liquid-injectable product.
 
Allergan will pay $65 million upfront and make additional payments of as much as $116.5 million based on certain development milestones, and as much as $180.5 million for certain commercialization milestones, and royalties on sales.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics